ArticleFrontiers in oncology2025

Donafenib intolerance in hepatocellular carcinoma: severe hand-foot skin reaction and successful switch to lenvatinib - a case report and literature review.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.